• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Second primary cancers after small-cell lung cancer].

作者信息

Soria J C, Bréchot J M, Lebeau B, Rochemaure J

机构信息

Service de pneumologie, Hôtel-Dieu, Paris, France.

出版信息

Bull Cancer. 1997 Aug;84(8):800-6.

PMID:9339185
Abstract

The records of 1,371 patients with small cell carcinoma of the lung (SCLC) treated between 1983 and 1994, were reviewed for the occurrence of second primary malignancies (SPM). One was excluded for analysis because of insufficient data. Eight synchronous SPM (SSPM) and 8 metachronous SPM (MSPM) were identified, SSPM included non-small cell lung cancer in 6 patients, 1 head and neck cancer and 1 oesophageal cancer. Median survival after the diagnosis of SSPM was 6 months. The MSPM were detected between 1 and 6 years after the diagnosis of SCLC. MSPM included lung cancer (3 patients), gastrointestinal malignancies (2 patients), 1 hematologic malignancy, 1 prostatic cancer and 1 head and neck cancer. The median survival time after the diagnosis of MSPM was 4 months. Occurrence of SPM is a singular pattern of patients with SCLC. Tobacco consumption, genetic factors and carcinogenic effects of multimodality treatment are supposed mechanisms to explain SPM.

摘要

相似文献

1
[Second primary cancers after small-cell lung cancer].
Bull Cancer. 1997 Aug;84(8):800-6.
2
Risk of subsequent primary neoplasms developing in lung cancer patients with prior malignancies.既往有恶性肿瘤的肺癌患者发生后续原发性肿瘤的风险。
J Thorac Cardiovasc Surg. 2004 Apr;127(4):1119-25. doi: 10.1016/j.jtcvs.2003.10.039.
3
[Second primary lung cancer in laryngeal cancer patients: report on 36 cases].喉癌患者的第二原发性肺癌:36例报告
Zhonghua Zhong Liu Za Zhi. 2001 Jul;23(4):341-3.
4
Effectiveness of intensive follow-up after response in patients with small cell lung cancer.
Lung Cancer. 2008 Feb;59(2):255-61. doi: 10.1016/j.lungcan.2007.08.016. Epub 2007 Sep 27.
5
[Risk of second primary cancer in two-year survivors of small cell lung cancer].[小细胞肺癌两年幸存者患第二原发性癌症的风险]
Nihon Kyobu Shikkan Gakkai Zasshi. 1996 Jul;34(7):741-6.
6
Neuroendocrine tumors and second primary malignancy--a relationship with clinical impact?神经内分泌肿瘤与第二原发性恶性肿瘤——二者存在具有临床影响的关联?
Anticancer Res. 2004 Mar-Apr;24(2C):1049-51.
7
Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma.头颈部鳞状细胞癌和鼻咽癌患者第二原发性恶性肿瘤的生存研究及治疗策略
Acta Otolaryngol. 2007 Jun;127(6):651-7. doi: 10.1080/00016480600951517.
8
Lung cancer patients with previous or simultaneous the upper aerodigestive cancers.曾患或同时患有上呼吸道和消化道癌症的肺癌患者。
Tuberk Toraks. 2009;57(2):192-7.
9
Surgical treatment of primary lung cancer with synchronous brain metastases.原发性肺癌伴同步脑转移的外科治疗
J Thorac Cardiovasc Surg. 2001 Sep;122(3):548-53. doi: 10.1067/mtc.2001.116201.
10
[Retrospective analysis of patients with small cell lung cancer treated at Gazi University Department of Radiation Oncology].[加齐大学放射肿瘤学系治疗的小细胞肺癌患者的回顾性分析]
Tuberk Toraks. 2005;53(2):139-47.

引用本文的文献

1
Risk of Second Primary Malignancies in Lung Cancer Survivors - The Influence of Different Treatments.肺癌幸存者发生第二原发性恶性肿瘤的风险——不同治疗方法的影响
Target Oncol. 2017 Apr;12(2):219-227. doi: 10.1007/s11523-016-0459-0.